Pharmacological treatment for epileptic seizures
| dc.contributor.advisor | Momtaz, Tanisha | |
| dc.contributor.author | Zohora, Umme Fathima Tuz | |
| dc.contributor.department | School of Pharmacy | |
| dc.date.accessioned | 2024-09-11T04:43:39Z | |
| dc.date.available | 2024-09-11T04:43:39Z | |
| dc.date.copyright | ©2024 | |
| dc.date.issued | 2024-04 | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. | en_US |
| dc.description | Cataloged from PDF version of thesis. | |
| dc.description | Includes bibliographical references (pages 23-25). | |
| dc.description.abstract | Epilepsy is a chronic neurological disorder that leads to uncontrollable recurrent seizures. This might occur either due to genetic or different environmental factors. Controlling epileptic seizures is of great challenge and so different antiepileptic drugs of generations first, second, third and so on were discovered throughout past few decades and are still under constant research. Drugs such as phenytoin, carbamazepine, ganaxolone, cannabidiol, lamotrigine, vigabatrin and many more were introduced under different generations. These drugs have different mechanisms of action such as enhancement of GABA action, inhibition of sodium channel and inhibition of calcium channel etc. Some of the newer AEDs are more emphasized and are under continuous research due to having fewer adverse effects that effectively control seizures accompanied by epilepsy. | en_US |
| dc.description.degree | Bachelor of Pharmacy | |
| dc.description.statementofresponsibility | Umme Fathima Tuz Zohora | |
| dc.format.extent | 25 pages | |
| dc.identifier.other | ID 20146053 | |
| dc.identifier.uri | http://hdl.handle.net/10361/24054 | |
| dc.language.iso | en | en_US |
| dc.publisher | Brac University | |
| dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Epilepsy | en_US |
| dc.subject | Seizures | en_US |
| dc.subject | GABA action | en_US |
| dc.subject | Neurological disorder | en_US |
| dc.subject | Cannabidiol | en_US |
| dc.subject | Ganaxolone | en_US |
| dc.subject.lcsh | Epileptics--Care. | |
| dc.subject.lcsh | Pharmacologie. | |
| dc.subject.lcsh | Brain stem--Abnormalities. | |
| dc.title | Pharmacological treatment for epileptic seizures | en_US |
| dc.type | Project Report | en_US |